Skip to menu Skip to content Skip to footer

2024

Conference Publication

Noxturnal cRIP: An alternative to AASM recommended flow sensors in analysis of respiratory events in polysomnography

Eriksson, N. and Burr, L. (2024). Noxturnal cRIP: An alternative to AASM recommended flow sensors in analysis of respiratory events in polysomnography. Sleep DownUnder 2024, Gold Coast, QLD Australia, 16-19 October 2024. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/sleepadvances/zpae070.116

Noxturnal cRIP: An alternative to AASM recommended flow sensors in analysis of respiratory events in polysomnography

2024

Conference Publication

Highly symptomatic patients have an increased risk of exacerbations and benefit from long-term macrolide treatment in Bronchiectasis

Sibila Vidal, Oriol, Stobo, Jamie, Perea, Lidia, Gao, Yong-Hua, Spinou, Arietta, Polverino, Eva, Ringshausen, Felix, Vendrell, Montserrat, Burgel, Pierre-Régis, Haworth, Charles S., Loebinger, Michael R., Lorent, Natalie, Dhar, Raja, Choi, Hayoung, Chotirmall, Sanjay, Hurst, John R., Brown, Jeremy S., Mcdonnell, Melissa, Van Der Eerden, Menno, Kauppi, Paula, Johnson, Emma D., Menendez, Rosario, Dimakou, Katerina, Bossios, Apostolos, Crichton, Megan L., Torres, Antoni, Welte, Tobias, Blasi, Francesco, Shteinberg, Michal ... Chalmers, James D. (2024). Highly symptomatic patients have an increased risk of exacerbations and benefit from long-term macrolide treatment in Bronchiectasis. ERS Congress 2024, Vienna, Austria, 7–11 September 2024. Sheffield, United Kingdom: European Respiratory Society. doi: 10.1183/13993003.congress-2024.pa2375

Highly symptomatic patients have an increased risk of exacerbations and benefit from long-term macrolide treatment in Bronchiectasis

2024

Conference Publication

Age-dependent dysregulation of the UPR in colonic epithelium: Implications for mucosal integrity

Illankoon, Thishan, Wong, Kuan Yau, Sajiir, Haressh, Mueller, Alexandra, Amiss, Anna, Begun, Jakob, Giri, Rabina, Burr, Lucy and Hasnain, Sumaira (2024). Age-dependent dysregulation of the UPR in colonic epithelium: Implications for mucosal integrity. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons.

Age-dependent dysregulation of the UPR in colonic epithelium: Implications for mucosal integrity

2024

Conference Publication

Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in Queensland

Wood, Michelle, Smith, Iain, Hiscock, Keirran, Smith, Daniel, Keating, Rebecca, Burr, Lucy, Tay, George, Zimmerman, Maureen, Feather, Iain, Cobb, Robyn, Moore, Vanessa, Evans, Ieuan, Reid, David, Masel, Philip, Mackintosh, John and Henderson, Daniel (2024). Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in Queensland. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2-4 August 2024. Richmond, VIC Australia: John Wiley & Sons.

Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in Queensland

2024

Conference Publication

Barriers to the annual OGTT: the patient perspective

Keating, Rebecca and Burr, Lucy (2024). Barriers to the annual OGTT: the patient perspective. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2-4 August 2024. Richmond, VIC Australia: John Wiley & Sons.

Barriers to the annual OGTT: the patient perspective

2024

Conference Publication

Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study

Mattison, Graeme, Keating, Rebecca, McWhinney, Brett, Connors, Shannon, Swenson, Rebecca, Evans, Ieuan, Burke, Andrew and Burr, Lucy (2024). Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2–4 August 2024. Richmond, VIC Australia: John Wiley & Sons.

Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study

2024

Conference Publication

Management of incretins: the future of glucose management in cystic fibrosis

Keating, Rebecca and Burr, Lucy (2024). Management of incretins: the future of glucose management in cystic fibrosis. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2-4 August 2024. Richmond, VIC Australia: John Wiley & Sons.

Management of incretins: the future of glucose management in cystic fibrosis

2024

Conference Publication

Plasma sulphate levels are elevated in bronchiectasis

Burr, L., Kelly, S., Anderson, S., McWhinney, A. and Dawson, P. (2024). Plasma sulphate levels are elevated in bronchiectasis. TSANZSRS 2024 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Gold Coast, QLD, Australia, 22–26 March 2024. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14673

Plasma sulphate levels are elevated in bronchiectasis

2024

Conference Publication

Evaluating the clinical utility of routine nasal nitric oxide

Madden, G., Carballo, A. and Burr, L. (2024). Evaluating the clinical utility of routine nasal nitric oxide. HOBOKEN: WILEY.

Evaluating the clinical utility of routine nasal nitric oxide

2023

Conference Publication

Biologic switching in severe asthma: Observations from an Australian patient cohort

Newman, B., Burr, L., Bowler, S. and Barnett, A. (2023). Biologic switching in severe asthma: Observations from an Australian patient cohort. HOBOKEN: WILEY.

Biologic switching in severe asthma: Observations from an Australian patient cohort

2021

Conference Publication

The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway disease

Rigauts, Charlotte, Aizawa, Juliana, Taylor, Steven, Rogers, Geraint, Govaerts, Matthias, Cos, Paul, Ostyn, Lisa, Sims, Sarah, Vandeplassche, Eva, Sze, Mozes, Dondelinger, Yves, Vereecke, Lars, Van Acker, Heleen, Simpson, Jodie, Burr, Lucy, Willems, Anne, Tunney, Michael, Cigana, Cristina, Bragonzi, Alessandra, Coenye, Tom and Crabbe, Aurelie (2021). The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway disease. European-Respiratory-Society (ERS) International Congress, Thessaloniki Greece, Sep 26-30, 2021. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2021.PA873

The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway disease

2020

Conference Publication

The educational needs of people with bronchiectasis in a pulmonary rehabilitation setting

Lee, Annemarie, Smith, Rebecca, Osadnik, Christian, Burr, Lucy, Chang, Anne, Holmes-Liew, Chien-Li, Jayaram, Lata, King, Paul, Middleton, Peter, Morgan, Lucy, Tu Nguyen, , Smith, Daniel, Stroil-Salama, Enna, Thomson, Rachel, Waring, Justin, Waterer, Grant, Wong, Conroy and Mcaleer, Rachel (2020). The educational needs of people with bronchiectasis in a pulmonary rehabilitation setting. ERS International Congress 2020, Online, 7–9 September 2020. Sheffield, United Kingdom: European Respiratory Society. doi: 10.1183/13993003.congress-2020.76

The educational needs of people with bronchiectasis in a pulmonary rehabilitation setting

2020

Conference Publication

Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries

Shoemark, Amelia, Finch, Simon, Torres, Antoni, Elborn, Stuart, Ringhausen, Felix, De Soyza, Anthony, Aliberti, Stefano, Blasi, Francesco, Dimakou, Katerina, Haworth, Charles, Hill, Adam, Loebinger, Michael, Vendrell, Montse, Welte, Tobias, Wilson, Robert, Crichton, Megan, Goeminne, Pieter, Burgel, Pierre-Regis, Polverino, Eva, Dhar, Raja, Singh, Sheetu, Talwar, Deepak, Mohan, Murali, Tripathi, Surya Kant, Swarnakar, Rajesh, Trivedi, Sonali, Rajagopala, Srinivas, D'Souza, George, Admanabhan, Arjun P. ... Chalmers, James D. (2020). Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries. International Congress of the European-Respiratory-Society (ERS), Electr Network, Sep 07-09, 2020. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2020.3335

Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries

2020

Conference Publication

Does gene modulation therapy improve glucose control in cystic fibrosis?

Keating, R., Burr, L. and Barrett, H. (2020). Does gene modulation therapy improve glucose control in cystic fibrosis?. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science TSANZSRS 2020, Melbourne, VIC Australia, 27-31 March 2020. Richmond, VIC Australia: John Wiley & Sons.

Does gene modulation therapy improve glucose control in cystic fibrosis?

2020

Conference Publication

Sustained effect of macrolide on sputum volume in bronchiectasis. The bless infinity study

Burr, L., Megan, M. and Simon, B. (2020). Sustained effect of macrolide on sputum volume in bronchiectasis. The bless infinity study. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science TSANZSRS 2020, Melbourne, VIC, Australia, 27-31 March 2020. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.13777

Sustained effect of macrolide on sputum volume in bronchiectasis. The bless infinity study

2020

Conference Publication

Carriage and transmission of macrolide resistance genes in patients with chronic lung diseases

Wang, Y., Taylor, S., Basham, J., Keating, R., Hindmarsh, K., Choo, J., Wesselingh, S., Burr, L. and Rogers, G. (2020). Carriage and transmission of macrolide resistance genes in patients with chronic lung diseases. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science TSANZSRS 2020, Melbourne, VIC Australia, 27-31 March 2020. Richmond, VIC Australia: John Wiley & Sons.

Carriage and transmission of macrolide resistance genes in patients with chronic lung diseases

2020

Conference Publication

Sitagliptin improves clinical outcomes in cystic fibrosis impaired glucose tolerance

Keating, R. and Burr, L. (2020). Sitagliptin improves clinical outcomes in cystic fibrosis impaired glucose tolerance. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science TSANZSRS 2020, Melbourne, VIC, Australia, 27-31 March 2020. Richmond, VIC Australia: John Wiley & Sons.

Sitagliptin improves clinical outcomes in cystic fibrosis impaired glucose tolerance

2020

Conference Publication

Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection

Hasnain, S., Wang, R., Taylor, S., Wong, K. Y., Moniruzzaman, M., Upham, J., Spann, K., Mcguckin, M. A., Burr, L. and Phipps, S. (2020). Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection. TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Melbourne, VIC, Australia, 27–31 March 2020. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.13777

Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection

2019

Conference Publication

A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis

Tong, Koliarne, Dorahy, Douglas, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Barker, Daniel and Wark, Peter (2019). A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis. International Congress of the European-Respiratory-Society (ERS), Madrid Spain, Sep 28-Oct 02, 2019. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2019.OA2126

A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis

2019

Conference Publication

Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis

Altenburg, Josje, Chalmers, James, Lonergan, Mike, Jayaram, Lata, Burr, Lucy, Crichton, Megan, Karalus, Noel, Martin, Megan, Taylor, Steven, Wong, Conroy and Boersma, Wim (2019). Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis. International Congress of the European-Respiratory-Society (ERS), Madrid Spain, Sep 28-Oct 02, 2019. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2019.OA4945

Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis